The Primacy of Public Health Considerations in Defining Poor Quality Medicines
نویسندگان
چکیده
1 Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR, 2 Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom, 3 WorldWide Antimalarial Resistance Network (WWARN), University of Oxford, Oxford, United Kingdom, 4 Malaria & Child Survival Department, Population Services International, Nairobi, Kenya, 5 Wellcome Trust, London, United Kingdom, 6 School of Pharmacy, Curtin University of Technology, Bentley, Western Australia, Australia, 7 University of Oslo, Oslo, Norway, 8 IHCAR Div Global Health, Karolinska Institute, Stockholm, Sweden, 9 IMANI Center for Policy & Education, Accra, Ghana, 10 American Enterprise Institute, Washington, D.C., United States of America, 11 Mahidol Oxford Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
منابع مشابه
Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication
Benefit package is crucial for implementing universal health coverage (UHC). This editorial analyses how the benefit package of the Thai Universal Coverage Scheme (UC Scheme) evolved from an implicit comprehensive package which covered all conditions and interventions (with a few exceptions), to additional explicit positive lists. In 2002 when the Thai UC Scheme was lau...
متن کاملDefining Pathways and Trade-offs Toward Universal Health Coverage; Comment on “Ethical Perspective: Five Unacceptable Trade-offs on the Path to Universal Health Coverage”
The World Health Organization’s (WHO’s) World Health Report 2010, “Health systems financing, the path to universal coverage,” promoted universal health coverage (UHC) as an aspirational objective for country health systems. Yet, in addition to the dimensions of services and coverage, distribution of coverage in the population, and financial risk protection highlighted by the report, the conside...
متن کاملWhat Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?
Background The unregulated availability and irrational use of tuberculosis (TB) medicines is a major issue of public health concern globally. Governments of many low- and middle-income countries (LMICs) have committed to regulating the quality and availability of TB medicines, but with variable success. Regulation of TB medicines remains an intractable challenge in many settings, but the reason...
متن کاملCountry Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
Introduction: Evaluation of pharmaceutical systems performance is an essential prerequisite for promoting evidence-based policy-making, improvement in health system performance. This study attempts to evaluate the performance of Iran pharmaceutical system based on the world health organization (WHO)'s indicators, including access, quality, and rational use of medicines. Methods: In this c...
متن کاملCountry Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
Introduction: Evaluation of pharmaceutical systems performance is an essential prerequisite for promoting evidence-based policy-making, improvement in health system performance. This study attempts to evaluate the performance of Iran pharmaceutical system based on the world health organization (WHO)'s indicators, including access, quality, and rational use of medicines. Methods: In this c...
متن کامل